![Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy - eBioMedicine Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy - eBioMedicine](https://www.thelancet.com/cms/asset/10b41fd7-16b6-4319-bd04-9d113ed095fb/gr1.jpg)
Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy - eBioMedicine
![Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0592-z/MediaObjects/12929_2019_592_Fig3_HTML.png)
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text
![Antigen and Antibody-Production Technologies | Research and Development | MBL | MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. Antigen and Antibody-Production Technologies | Research and Development | MBL | MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD.](https://www.mblbio.com/e/r_and_d/images/SPYMEG01_e.jpg)
Antigen and Antibody-Production Technologies | Research and Development | MBL | MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD.
![In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model - ScienceDirect In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124718316516-fx1.jpg)
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model - ScienceDirect
![Frontiers | Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose? Frontiers | Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?](https://www.frontiersin.org/files/Articles/660037/fimmu-12-660037-HTML-r1/image_m/fimmu-12-660037-g001.jpg)
Frontiers | Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?
![Biocytogen Launches RenNano® Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery - Biocytogen Biocytogen Launches RenNano® Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery - Biocytogen](https://i0.wp.com/renmab.com/wp-content/uploads/renmice-rennano-registered.png?resize=801%2C451&ssl=1)
Biocytogen Launches RenNano® Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery - Biocytogen
![Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0592-z/MediaObjects/12929_2019_592_Fig2_HTML.png)
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text
![Frontiers | The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies Frontiers | The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies](https://www.frontiersin.org/files/Articles/540270/fimmu-11-01951-HTML/image_m/fimmu-11-01951-g001.jpg)